Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Announces Brokered LIFE Financing

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Oct 23, 2023 8:35pm

171 Views

Post# 35697407

RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE Financing

N0taP00p wrote: Sigh. You are correct. This is a 7-10% dilution give or take, including the commission to RC. Assuming it even gets filled. I'm expecting a 20% haircut in share price tomorrow. God help us. And Bud, stop being right. It hurts people.

The opposite can happen. The only thing holding this back was lack of funds. Now that they will be ok for about 10-16 months depending on amount raised, SP should not be pulled down. IMHO

<< Previous

Bullboard Posts

Next >>

AI companies to invest in